FGF10 and Alzheimer disease: Our western blotting results revealed a significant reduction in FGF10 levels in the cortex and hippocampus of 3xTg‐AD mice compared to wild‐type mice, with an increase in FGF10 levels observed after intranasal administration of FGF10 (Figure 1e,f).